Growth Metrics

Cresco Labs (CRLBF) Other Non-Current Liabilities (2020 - 2026)

Cresco Labs filings provide 7 years of Other Non-Current Liabilities readings, the most recent being $184.9 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 36.15% to $184.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $184.9 million, a 36.15% increase, with the full-year FY2025 number at $171.5 million, changed N/A from a year prior.
  • Other Non-Current Liabilities hit $184.9 million in Q1 2026 for Cresco Labs, up from $171.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $184.9 million in Q1 2026 to a low of $7.0 million in Q3 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $135.8 million (2025), compared with a mean of $90.3 million.
  • Biggest five-year swings in Other Non-Current Liabilities: decreased 18.14% in 2022 and later soared 522.14% in 2025.
  • Cresco Labs' Other Non-Current Liabilities stood at $12.9 million in 2022, then skyrocketed by 56.67% to $20.2 million in 2023, then skyrocketed by 658.94% to $153.4 million in 2024, then rose by 11.79% to $171.5 million in 2025, then rose by 7.83% to $184.9 million in 2026.
  • The last three reported values for Other Non-Current Liabilities were $184.9 million (Q1 2026), $171.5 million (Q4 2025), and $165.2 million (Q3 2025) per Business Quant data.